受体酪氨酸激酶
整合素
癌症研究
受体
原癌基因酪氨酸蛋白激酶Src
化学
新生血管
血管生成
细胞生物学
药理学
酪氨酸激酶
医学
肽
生物化学
生物
作者
Raquel Lima e Silva,Yogita Kanan,Adam C. Mirando,Jayoung Kim,Ron B. Shmueli,Valeria E. Lorenc,Seth D. Fortmann,Jason Sciamanna,Niranjan B. Pandey,Jordan J. Green,Aleksander S. Popel,Peter A. Campochiaro
标识
DOI:10.1126/scitranslmed.aai8030
摘要
AXT107 also reduced total VEGFR2 levels by increasing internalization, ubiquitination, and degradation. This biomimetic peptide is a sustained, multitargeted therapy that may provide advantages over intraocular injections of specific VEGF-neutralizing proteins.
科研通智能强力驱动
Strongly Powered by AbleSci AI